HomeInsightsPE

Aarti Drugs Ltd PE Ratio

Aarti Drugs Ltd PE Ratio

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Dec 13, 2024)

stocks purchased

8.2 K

Stocks Traded

(Dec 13, 2024)

Last Updated on: Dec 14, 2024

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

PE

26.9

Last updated on: Dec 14, 2024

Key Highlights

  • The P/E Ratio of Aarti Drugs Ltd is 26.9 as of 14 Dec 9.00 AM .
  • The P/E Ratio of Aarti Drugs Ltd changed from 16.8 on March 2019 to 23.3 on March 2024 . This represents a CAGR of 5.60% over 6 years.
  • The Latest Trading Price of Aarti Drugs Ltd is ₹ 444.95 as of 13 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Aarti Drugs Ltd

No data available

Company Fundamentals for Aarti Drugs Ltd

No data available

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

Share Price

₹ 444.95

-1.10 (-0.25%)

stock direction

Last updated on: Dec 13, 2024

Market Price of Aarti Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Dec 2024444.95
12 Dec 2024446.05
11 Dec 2024453.75
10 Dec 2024444.7
09 Dec 2024455.55
06 Dec 2024455.25
05 Dec 2024455.3
04 Dec 2024459.25
03 Dec 2024461.95
02 Dec 2024458.15

SWOT Analysis Of Aarti Drugs Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Aarti Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aarti Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Aarti Drugs Ltd264,090
Sun Pharmaceuticals Industries Ltd384,35,179
Divis Laboratories Ltd851,55,995
Cipla Ltd251,16,890
Torrent Pharmaceuticals Ltd651,13,295
Mankind Pharma Ltd501,05,787

Key Valuation Metric of Aarti Drugs Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Aarti Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Aarti Drugs Ltd

No data available

* All values are in %

About Aarti Drugs Ltd

  • Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals.
  • The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million.
  • With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
  • It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra.
  • It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary).

Aarti Drugs Ltd News Hub

News

Aarti Drugs hit 52-week high as board OKs Rs 60-cr share buyback

The buyback price fixed at Rs 900 per equity share, representing a 59.66% premium to Frida...

Read more

2024-08-26 00:00:00

News

Aarti Drugs to consider buyback

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 26 August 2024...

Read more

2024-08-22 00:00:00

News

Aarti Drugs soars on share buyback proposal

The announcement was made after market hours yesterday. Aarti Drugs forms part of $6 Billi...

Read more

2024-08-22 00:00:00

News

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up ...

Read more

2024-08-26 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Aarti Drugs Ltd

What is the current PE Ratio of Aarti Drugs Ltd?

The Current PE Ratio of Aarti Drugs Ltd is 26.87 as on 14 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 14 Dec 2024.

What was the PE Ratio of Aarti Drugs Ltd last year?

The PE Ratio of Aarti Drugs Ltd was 18.81 last year, now the PE ratio is 26.87, showing a year-on-year growth of 42.8%.

What does the PE Ratio of Aarti Drugs Ltd indicate about its stock?

The PE Ratio of Aarti Drugs Ltd is 26.87. This ratio indicates that investors are willing to pay 26.87 times the earnings per share for each share of Aarti Drugs Ltd.

What is the PE Ratio Growth of Aarti Drugs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Aarti Drugs Ltd grew by 42.8% whereas, the EPS ratio grew by 5.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions